Профиль

Nate Holdren

Hey bluesky. Historian. In decline. Views expressed here are those of a future insightful majority.

8,6 тыс. подписчиков970 подписок6 тыс. постов
Публикации
⟳ Репост от Nate Holdren

Today, @nhold.bsky.social explains why calls for mandatory retirement are mistaken, and what this mistake indicates about the character of elite academic circles, including the law and political economy movement.

What Rolls DownhillRecent calls for mandatory retirement in academia are a reminder that class and other social hierarchies are something like mountains with increasingly dense fog toward their peaks: the higher up one…lpeproject.org
⟳ Репост от Nate Holdren

I am 53 and have been essentially forced into retirement. I thought it was just me, until I found an entire community of women in the same situation on Instagram. So many of us have just been told that we simply have nothing to contribute to society anymore.

Karen K. Ho

I keep thinking about how often the mass layoffs in media, government and big companies, especially women and people of color, will lead to poorer outcomes for years because the people who would point out potential problems or blind spots were deemed non-essential, a "bad fit", and/or too expensive.

⟳ Репост от Nate Holdren

I am so excited to announce the pre-sale for my forthcoming book, The Struggle Is Always Worth It! This is also the first reveal of the table contents, and let me tell you, there are some superstars who contributed to this book. givebutter.com/SIAWI-presale

Struggle Is Always Worth It book pre-salePre-sale and fundraiser for the edited collection, The Struggle Is Always Worth It, coming out December 2026.givebutter.com

I'm not well informed enough to fully back this up but it at least feels like a great deal of contemporary US politics, both parties but Trumpworld especially so, is basically naked corruption with some ideological window dressing. kleptocracy kinda thing

Paul Bleicher

Astonishing. RFK Jr. adds 8 members to a 6 member FDA advisory panel. 6 of them were sellers of peptides, and the 7th a compounding pharmacist. In an 8-6 vote with all 8 votes coming from these new panel members, the panel approved 4 peptides against the objections of FDA scientists.

Следующие публикации